Showing 5,845 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

New & experimental HIV treatments

From sky high to CHAI – what needs to be done about dolutegravir pricing?

Editor's pick
HIV I-Base
2 October 2013
New & experimental HIV treatments

Stribild is effective and well tolerated in older people with HIV

News
2 October 2013
HIV treatment

CROI abstract submission closes 8 October

Editor's pick
CROI 2014
30 September 2013
New & experimental HIV treatments

European Commission Approves Gilead Sciences' Tybost(TM), a New Boosting Agent for HIV Therapy

Editor's pick
Gilead press release
26 September 2013
Adherence

Single-tablet regimen improves antiretroviral adherence and reduces hospitalisation

News
26 September 2013
PrEP

PATH Evaluates Janssen’s Rilpivirine as HIV Infection Prophylactic

Editor's pick
Genetic Engineering & Biotechnology News
25 September 2013
New & experimental HIV treatments

CHMP recommends that Vitekta (elvitegravir) should be granted marketing authorisation

Editor's pick
European Medicines Agency
25 September 2013
The search for a cure

Nail Fungus Drug Might Help Against HIV: Study

Editor's pick
WebMD
25 September 2013
Pharmaceutical industry

Seven Ways to Speed up the HIV Treatment Pipeline

Editor's pick
Positive Lite
24 September 2013
Side effects

Switching from Atripla to Eviplera reduces central nervous system side-effects

News
23 September 2013
New & experimental HIV treatments

Good safety profile with long-acting integrase inhibitor, GSK744

Editor's pick
NATAP
19 September 2013
How HIV works

Gene discovery could lead to new types of HIV treatments

Editor's pick
Reuters
19 September 2013
Side effects

Crofelemer effective for severe or PI-related diarrhea in placebo trial

Editor's pick
NATAP
19 September 2013
Bone & joint problems

TDF/FTC-to-ABC/3TC switch maintains viral suppression, eases bone markers

Editor's pick
NATAP
19 September 2013
Treatment guidelines

"If I am given antiretrovirals I will think I am nearing the grave" – a challenge for early treatment strategies

News
19 September 2013
New & experimental HIV treatments

Will Germany Squelch Gilead Hopes For Its Stribild AIDS Drug?

Editor's pick
Pharmalot
19 September 2013
Pregnancy and vertical transmission

Raltegravir appears safe for mothers and babies during pregnancy

News
18 September 2013
New & experimental HIV treatments

Novel NNRTI AIC292 works well against drug-resistant HIV

News
17 September 2013
Drug interactions & pharmacokinetics

New NNRTI MK-1439 interacts with ritonavir but not tenofovir

News
17 September 2013
Finance & funding

Second- and Third-Line ART Cost 24% and 41% More Than First Line in US

Editor's pick
NATAP
17 September 2013
New & experimental HIV treatments

Dolutegravir shows good efficacy across broad range of patient groups

News
17 September 2013
Bad science & bogus treatments

Pat Robertson Loses Fight to Keep 'Gay AIDS Ring' Video Off The Internet

Editor's pick
Right Wing Watch
16 September 2013
Treatment guidelines

A new weapon in Myanmar's fight against HIV

Editor's pick
Al Jazeera
16 September 2013
Adherence

Single HIV Pill More Likely to Foster Adherence (CME/CE)

Editor's pick
MedPage Today HIV/AIDS
16 September 2013